Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes.

Autor: Bashier, Alaaeldin¹ alaaeldin11@gmail.com, Khalifa, Azza Abdulaziz¹, Abdelgadir, Elamin Ibrahim¹, Al Saeed, Maryam Ahmad¹, Al Qaysi, Amina Adil², Ali Bayati, Murad Burhan², Alemadi, Budoor¹, Bachet, Fawzi¹, Alawadi, Fatheya¹, Hassanein, Mohammed¹

Publikováno v: Oman Medical Journal. Mar2018, Vol. 33 Issue 2, p104-110. 7p.

Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes.

Autor: Bashier A; Endocrine Department, Dubai Hospital, Dubai, United Arab Emirates., Khalifa AA; Endocrine Department, Dubai Hospital, Dubai, United Arab Emirates., Rashid F; Endocrine Department, Dubai Hospital, Dubai, United Arab Emirates., Abdelgadir EI; Endocrine Department, Dubai Hospital, Dubai, United Arab Emirates., Al Qaysi AA; Internal Medicine Residency Program, Dubai Hospital, Dubai, United Arab Emirates., Ali R; Internal Medicine Residency Program, Dubai Hospital, Dubai, United Arab Emirates., Eltinay A; Emergency Medicine Residency Program, Rashid Hospital, Dubai, United Arab Emirates., Nafach J; Dubai Diabetes Centre, Dubai, United Arab Emirates., Alsayyah F; Endocrine Department, Dubai Hospital, Dubai, United Arab Emirates., Alawadi F; Endocrine Department, Dubai Hospital, Dubai, United Arab Emirates.

Publikováno v: Journal of clinical medicine research [J Clin Med Res] 2017 Jun; Vol. 9 (6), pp. 499-507. Date of Electronic Publication: 2017 Apr 26.